Quick Overview: Interview with Christopher J. Moreau, CEO of CEO Chris Moreau and VP Research & Operations, Dr. Chris Bryan discuss topline data from the Phase 2b/3 COVID-19 trial of ... CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and plans and milestones for
Algernon Pharmaceuticals Gets Green Light - Detailed Overview & Context
Interview with Christopher J. Moreau, CEO of CEO Chris Moreau and VP Research & Operations, Dr. Chris Bryan discuss topline data from the Phase 2b/3 COVID-19 trial of ... CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and plans and milestones for Interview with Christopher Moreau, CEO of Interview with CEO Christopher Moreau and host Cyndi Edwards regarding news about the next steps in
